EDGAR Filing Documents for 0001193125-14-391396

Form 8-K - Current report:

SEC Accession No. 0001193125-14-391396

Filing Date

2014-10-31

Accepted

2014-10-31 11:40:37

Documents

Period of Report

2014-10-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d811418d8k.htm	8-K	61836
2	EX-3.1	d811418dex31.htm	EX-3.1	46502
3	EX-3.2	d811418dex32.htm	EX-3.2	4711
4	EX-10.1	d811418dex101.htm	EX-10.1	73373
5	EX-99.1	d811418dex991.htm	EX-99.1	14300
	Complete submission text file	0001193125-14-391396.txt		202441

Mailing Address 75 KNEELAND STREET 6TH FLOOR BOSTON MA 02111

Business Address 75 KNEELAND STREET 6TH FLOOR BOSTON MA 02111 (617) 275-0040

Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)